Indian drug firm challenges GSK, Pfizer in race for multi-billion-dollar aid-financed vaccine market
NewsFebruary 20, 2018
The Indian pharmaceutical company Serum Institute says its pneumonia vaccine will be ready for sale in developing countries by 2020 at a fraction of the going price. This places Serum in direct competition with two Western drug manufacturers, GSK and Pfizer, which have dominated the aid- financed pneumonia vaccine market for the last decade.
The rest of the content is only available for subscribers.